- Home
- DAO vs AMLX Comparison
DAO vs AMLX Comparison
Compare DAO & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAO | AMLX |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DAO | AMLX |
|---|---|---|
| Price | $12.59 | $18.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $21.56 |
| AVG Volume (30 Days) | 81.6K | ★ 1.8M |
| Earning Date | 05-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $380,786,000.00 |
| Revenue This Year | $12.24 | N/A |
| Revenue Next Year | $14.60 | N/A |
| P/E Ratio | $72.35 | ★ N/A |
| Revenue Growth | N/A | ★ 1612.94 |
| 52 Week Low | $8.30 | $7.48 |
| 52 Week High | $13.04 | $19.15 |
Technical Indicators
Market Signals| Indicator | DAO | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 58.05 | 69.75 |
| Support Level | $9.30 | $12.17 |
| Resistance Level | $12.82 | $18.61 |
| Average True Range (ATR) | 0.93 | 1.04 |
| MACD | 0.10 | 0.33 |
| Stochastic Oscillator | 93.42 | 83.43 |
Price Performance
Historical ComparisonAbout DAO Youdao Inc. each representing one
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.